CSEA3 Annual Meeting

Programme

We are pleased to present the official program of the CSEA3 Annual Meeting.
The schedule below outlines keynote lectures, thematic sessions, panel discussions, and networking opportunities designed to foster the exchange of ideas and collaboration among participants.

TimeTitleSpeaker
10:00 – 11:30Drug allergyWerner Pichler (Switzerland)
10:00 – 11:30Severe asthmaAleksandra Kucharczyk (Poland)
11:30 – 13:00Allergen immunotherapy (AIT)Krzysztof Kowal (Poland)
11:30 – 13:00In vitro diagnosticsCarmen Panaitescu (Romania)
11:30 – 13:00Food allergytbd
CSEA3 President Dejan Dokic (North Macedonia)
Congress Chair Marek Jutel (Poland)
Congress Chair Ioana Agache (Romania)
Congress Chair Radoslaw Gawlik (Poland)
CHAIRS:
  • Radoslaw Gawlik (Poland)
  • Ioana Agache (Romania)
TimeTitleSpeaker
14:15 – 14:45New insights from asthmaLuis Pérez de Llano (Spain)
14:45 – 15:15New insights from CRSWhitney Stevens (US)
15:15 – 15:45New insights from ADEster Del Duca (Italy)
15:45 – 16:15Strategies for prevention and management of severe reactions in food allergyAnna Nowak-Wegrzyn (US)
16:15 – 16:45AIT versus biologicalsMarek Jutel (Poland)
CHAIRS:
  • Luis Pérez de Llano (Spain)
  • Werner Pichler (Switzerland)
TimeTitleSpeaker
17:15 – 17:45Mechanisms and biomarkersIoana Agache (Romania)
17:45 – 18:15The impact of biologicalsCeleste Porsbjerg (Denmark)
18:15 – 18:45Achieving long-term treatment benefits in severe asthma patientsPeter Howarth (UK)
CHAIRS:
  • Ioana Agache (Romania)
TimeTitleSpeaker
18:45 – 18:55Introduction: Rationale for AIT in multimorbid allergic patients.Ioana Agache (Romania)
18:55 – 19:05AIT and severe asthmaMarek Jutel (Poland)
19:05 – 19:15AIT and atopic dermatitisRadosław Gawlik (Poland)
19:15 – 19:25AIT and autoimmunityKrzysztof Kowal (Poland)
CHAIRS:
  • Magdalena Zemelka-Wiącek (Poland)
  • Carmen Panaitescu (Romania)
TimeTitleSpeaker
08:30 – 08:50Immunophenotyping of peripheral blood eosinophils in patients with asthmaJakub Novosad (Czech Republic)
08:50 – 09:10Genetic markers of nasal polyposis and asthma: insights from Croatian patientsAnamarija Štajduhar (Croatia)
09:10 – 09:30The small airways syndromeMaciej Kupczyk (Poland)
09:30 – 10:00The potential of skin tapesEster del Duca (Italy)
CHAIRS:
  • Piotr Kuna (Poland)
TimeTitleSpeaker
10:30 – 10:35Evolution of biological treatment of asthmaPiotr Kuna
(Poland)
10:35 – 10:55Depemokimab: Ultra Long-Acting biological for severe asthmaMaciej Kupczyk
(Poland)
10:55 – 11:15Ultra-long-acting drugs in the treatment of respiratory diseases – what do they bring to clinical practice?Radosław Gawlik
(Poland)
11:15 – 11:30Persistence of the biological treatment effect in severe asthma – review of the published dataAlicja Majos
(Poland)
TimeTitleSpeaker
10:30 – 11:30Warsztaty (prowadzone w języku polskim): Immunoterapia w praktyce klinicznej – aktualna wiedza i interesujące przypadki klinicznePaweł Majak (Poland)
CHAIRS:
  • Anna Nowak-Wegrzyn (US)
  • Mira Pevec (Croatia)
TimeTitleSpeaker
11:30 – 12:00The efficacy and safety of immunotherapy in children with food allergySharon Chinthrajah (US)
12:00 – 12:30Point-of-care blood eosinophils to predict preschool wheeze attacksSejal Saglani (UK)
12:30 – 12:45Clinical manifestations of atopy in childrenDejan Djokić (North Macedonia)
12:45 – 13:00Early presentation of hereditary angioedema symptoms in a 2-year-old boyJūratė Staikūnienė-Kozonis (Lithuania)
CHAIRS:
  • Tonya Winders (US)
  • Maris Bukovskis (Latvia)
TimeTitleSpeaker
14:00 – 14:30Climate change and aeroallergensAthanasios Damialis (Greece)
14:30 – 15:00Nature-based solutionsTari Haahtela (Finland)
15:00 – 15:30Environmental endotypesIoana Agache (Romania)
TimeTitleSpeaker
14:15 – 15:15 Warsztaty (prowadzone w języku polskim): Wstrząs anafilaktyczny w praktyce: rozpoznanie i podawanie adrenaliny Karina Jahnz-Różyk
Radosław Gawlik
Anna Kosowska
Marek Jutel
(Poland)
CHAIRS:
  • Vera Mahler (Germany)
  • Laura Malinauskienė (Lithuania)
TimeTitleSpeaker
16:00 – 16:20Experiences with an ultra-rush protocol for the initiation of hymenoptera venom immunotherapy using depot preparationsTomáš Balner (Czech Republic)
16:20 – 16:40Venom allergy – diagnosis and treatmentPeter Kopač (Slovenia)
16:40 – 17:00Status of AIT in Central and Eastern Europe – results of the CSEA3 surveyMagdalena Zemelka-Wiacek (Poland)
17:00 – 17:30New AIT GuidelinesMarek Jutel (Poland)
TimeTitleSpeaker
17:30 – 18:30 (prowadzone w języku polskim): Immunoterapia alergenowa (AIT) w niejednoznacznych przypadkach klinicznych – aspekty diagnostyczno-terapeutyczne Marek Jutel (Poland)
Marita Nittner-Marszalska (Poland)
CHAIRS:
  • Karina Jahnz-Różyk (Poland)
  • tbd
TimeTitleSpeaker
08:30 – 08:50Assessment of rhinitis using the exposure chamberMagdalena Zemelka-Wiacek (Poland)
08:50 – 09:20Molecular allergology in daily practiceJoana Vitte (France)
09:20 – 09:50Ensuring the quality of diagnostic testsVera Mahler (Germany)
09:50 – 10:15Novel techniques for skin testingSven Seys (Belgium)
10:15 – 10:30Diagnosing contact allergyLaura Malinauskiene (Lithuania)
CHAIRS:
  • Tomáš Balner (Czech Republic)
  • tbd
TimeTitleSpeaker
11:00 – 11:30Co-creation of the management planTonya Winders (US)
11:30 – 11:55Biological treatment of chronic rhinosinusitis with polyps -real-life experienceRadoslaw Gawlik (Poland)
11:55 – 12:20Asthma managementMarcin Moniuszko (Poland)
12:20 – 12:45Drug and food allergyIwona Poziomkowska-Gęsicka (Poland)
At the end of the congress, the key points will be summarized by Marek Jutel and Ioana Agache.